PETALING JAYA: The vaccines produced by Sinovac and Pfizer-BioNTech are equally effective in preventing severe Covid-19 infections, says Tan Sri Dr Noor Hisham Abdullah. He cited a report published in the New England Journal of Medicine on July 7 which detailed the use of the Sinovac vaccine in Chile from February to May. “Sinovac was found to reduce Covid-19 infection by 65.9%, reduce hospitalisation by 87.5%, reduce ICU admissions by 90.3% and reduce deaths by 86.3%,” he said in a Facebook post on Tuesday (July 20). “Therefore, there is not much difference between the Sinovac and Pfizer vaccines in actual practical use. Both are very effective at preventing severe disease and hospitalisation, but less effective against mild or asymptomatic Covid-19,” he said.

Source: The Star July 20, 2021 07:31 UTC